Evaluation of BAL Procedure With Ambu aScope 3 Large in Patients in an ICU Setting
NCT ID: NCT03581474
Last Updated: 2020-02-13
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
12 participants
INTERVENTIONAL
2017-09-28
2018-07-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pulmonary Ventilation After Fiberoptic Bronchoscopy Using EIT
NCT05875662
Assessment of Occult Lung Stress During Lung Protective Mechanical Ventilation
NCT05675696
ARDS Esophageal Balloon Pressure Changes With Positioning Study
NCT03120793
The Utility of Regional Bioimpedance in Chronically Ventilated Patients
NCT02951936
Potential Biomarkers and Pathogenic Mechanism for Reflux Aspiration-induced Lung Injury.
NCT06164639
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
aScope 3 Large
Bronchoscopic procedure
Bronchoscopic procedure
Single-use flexible bronchoscope aScope 3 Large
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bronchoscopic procedure
Single-use flexible bronchoscope aScope 3 Large
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical indication and eligible for a BAL procedure, as judged by the investigator
* Patients being admitted in the ICU at the investigational centre
* Provision of signed IC by subject, or subject's legal representative e.g. next of kin
Exclusion Criteria
* ETT \>7 mm and ≤8.5 mm in diameter
* Participating in other interventional clinical investigations or have previously participated in this investigation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ambu A/S
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anna Charlotte Lundgaard
Role: STUDY_CHAIR
Ambu A/S
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Chicago Medicine
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIS-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.